Research libraryMelanocortin and GnRH peptides
Gonadorelin vs hCG: A Research Compound Comparison
For laboratory research use only. The compounds discussed here are sold strictly for in vitro research. They are not drugs, supplements or cosmetics and are not for human or animal use. This article summarizes published literature for reference and is not medical or usage advice.
People keep putting gonadorelin and hCG side by side, which is a bit funny, because they barely resemble each other. Gonadorelin is tiny, ten amino acids, and it pokes the pituitary. hCG is a bulky two-subunit glycoprotein, and it works far downstream at the gonad. About all they share is the cascade they both plug into, at opposite ends. So what do the primary papers actually say? We dug through them. Here’s the breakdown, receptor by receptor, citations included so you don’t have to take our word for it.
Key findings
- Gonadorelin is just synthetic GnRH (gonadotropin-releasing hormone). Schally’s lab pulled the decapeptide pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 out of porcine hypothalamus in 1971 [1][2].
- Its target is the GnRH receptor, a GPCR sitting on pituitary gonadotrophs that wasn’t cloned until 1992 [3].
- It doesn’t hang around. Half-life measured near 2.4 minutes after an intravenous bolus in human volunteers [4].
- Pulses are the whole trick. Steady infusion into lesioned monkeys sustained nothing, while one pulse an hour brought gonadotropin output back [5].
- hCG is a different animal, a glycoprotein made of a shared alpha subunit plus its own beta subunit, and it hits the lutropin-choriogonadotropin receptor instead [6][7].
What gonadorelin is
Gonadorelin is the lab-made copy of gonadotropin-releasing hormone, GnRH, which older papers call LHRH or LH-RH. Ten amino acids, sequence pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2. And that sequence wasn’t a lucky guess. Matsuo, Baba, Schally and the rest teased it out of porcine hypothalamic extract in 1971, then proved it by building the peptide from scratch and watching the natural and synthetic versions behave identically [1][2].
Your hypothalamus makes GnRH and dumps it into the little portal circulation that feeds the pituitary. Down there it tells the gonadotrophs to let go of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The line from Schally’s 1971 Science paper that really stuck around: one polypeptide handles the release of both LH and FSH [2]. Everybody had assumed there were two separate factors doing this. Nope, just one.
The receptor, and why pulses matter
Gonadorelin latches onto the GnRH receptor, a G protein-coupled receptor on the surface of pituitary gonadotrophs. Tsutsumi’s group cloned the mouse version in 1992. What they found was a 327-amino-acid protein carrying the seven transmembrane domains you expect from a GPCR, except it was missing the usual intracellular C-terminal tail [3]. Odd little quirk, and it may feed into how the receptor keeps itself in check.
And that self-regulation is really the whole story here. Knobil’s team nailed it in 1978. Take rhesus monkeys whose hypothalamic lesions had killed off their own gonadotropin release, pour in a constant GnRH infusion, and nothing happens. Swap to one pulse an hour, matching the body’s own rhythm, and pituitary secretion wakes right back up [5]. Here’s the part I like: once pulses had restored the animals, flipping back to continuous infusion desensitized everything and shut it down a second time. Pattern wins over amount. And a peptide this short-lived is practically built to be pulsed.
Pharmacokinetics: here and gone
How short-lived? Fauconnier’s group put synthetic LH-RH into six human volunteers in 1978, drew blood every 20 to 30 seconds, and clocked the half-life at 2.4 plus or minus 0.4 minutes [4]. They also saw that not much of the material given stuck around in the bloodstream, which hints it moves out into tissue fast.
A roughly two-and-a-half-minute half-life is the physical reason this hormone works as pulses instead of a steady hum. It’s also one of the big ways gonadorelin and hCG part company, which we’ll get to.
What hCG is, and how it differs
hCG is a whole different kind of molecule. It’s a glycoprotein hormone, the family Pierce and Parsons mapped out in their 1981 review. Each one is built from two subunits: a common alpha shared across the family, plus a beta that’s specific to the hormone and gives it its identity [6]. They’re loaded with sugar chains, hence glycoprotein, and dwarf a ten-residue peptide.
And hCG skips the pituitary completely. It works at the gonad, on the lutropin-choriogonadotropin receptor (LH-CG receptor for short), which McFarland’s group cloned in 1989. Their receptor had a big 341-residue extracellular domain to grab the hormone, plus the seven-transmembrane stretch that flags it as a GPCR, and cells carrying it bound human choriogonadotropin tightly and answered with a jump in cyclic AMP [7]. Since hCG imitates LH right at that receptor, it basically steps in downstream, whereas gonadorelin works a level up by coaxing the pituitary to release its own LH and FSH.
Side-by-side
| Gonadorelin (GnRH) | hCG | |
|---|---|---|
| Molecular class | Decapeptide, 10 residues [1] | Glycoprotein hormone, alpha + beta subunits [6] |
| Site of action | Pituitary gonadotrophs | Gonadal LH-CG receptor [7] |
| Receptor | GnRH receptor (GPCR) [3] | LH-CG receptor (GPCR) [7] |
| Position in cascade | Upstream (triggers LH/FSH release) [2] | Downstream (mimics LH at gonad) |
| Plasma half-life | ~2.4 min [4] | Long (glycosylation slows clearance) [6] |
| Delivery pattern | Pulsatile required [5] | Single long-acting signal |
Why the half-life gap exists
The clearance difference isn’t random. The carbohydrate chains on glycoprotein hormones like hCG slow their removal from circulation, which is part of why hCG acts as a sustained signal while gonadorelin is gone in minutes [6]. In practical research terms, that means the two molecules produce very different time courses at their respective receptors even before you consider where those receptors sit.
Handling and characterization
Both are peptide or protein products, so the same analytical and stability questions apply as with any synthetic peptide. GnRH itself was both isolated from tissue and chemically synthesized in the original 1971 work, and the synthetic and natural forms shared biological properties, which is the historical baseline for identity confirmation here [2]. For a research compound, identity is confirmed by mass against the known sequence and purity by chromatography. If you want the detail on how that testing works and what a certificate of analysis can and can’t tell you, we covered it in our piece on third-party tested peptides, and batch documentation lives on our certificates of analysis page.
FAQ
Is gonadorelin the same as GnRH?
Yes. Gonadorelin is the synthetic form of gonadotropin-releasing hormone, the decapeptide sequenced in 1971 [1][2].
Why does gonadorelin have to be pulsed?
Because the GnRH system responds to the pattern of signal, not just the amount. Continuous exposure desensitizes the pituitary, while hourly pulses sustain gonadotropin release [5]. The peptide’s ~2.4-minute half-life fits that pulsatile biology [4].
Do gonadorelin and hCG act on the same receptor?
No. Gonadorelin acts on the pituitary GnRH receptor; hCG acts on the gonadal LH-CG receptor. They’re different GPCRs at different points in the cascade [3][7].
References
- Matsuo H, Baba Y, Nair RM, Arimura A, Schally AV. Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun. 1971. PMID 4936338
- Schally AV, Arimura A, Kastin AJ, et al. Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science. 1971. PMID 4938639
- Tsutsumi M, Zhou W, Millar RP, et al. Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol. 1992. PMID 1324422
- Fauconnier JP, Teuwissen B, Thomas K. Rate of disappearance in plasma of synthetic LH-RH intravenously injected in man. Gynecol Obstet Invest. 1978. PMID 378777
- Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science. 1978. PMID 100883
- Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981. PMID 6267989
- McFarland KC, Sprengel R, Phillips HS, et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science. 1989. PMID 2502842